The Board of Trustees

The Board of Trustees includes six internationally renowned scientists, the Chairman of the Board of Managing Directors of Boehringer Ingelheim and, as a permanent guest, a representative of the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation). The trustees work in an honorary capacity and decide on all matters of general importance. Their most important function, however, is to act as an independent committee of experts that scrutinizes the applications for PhD and MD fellowships and that reviews the proposals for International Titisee Conferences.

From the very beginning, the Boehringer Ingelheim Fonds succeeded in appointing as trustees personalities from universities and other basic research institutes, who were not only distinguished scientists, but who also enjoyed the confidence of their fellow researchers. Their high demands on quality and their stringent selection criteria have gained the Foundation recognition by the scientific community.

The trustees are appointed by the founders for a tenure of three years; renewal is possible.

Members of the Board of Trustees

• Professor Dr. med. Dr. sc. math. Andreas Barner, Boehringer Ingelheim GmbH, Ingelheim am Rhein, Germany (Chairman; Executive Committee);
• Professor Dr. med. Peter Herrlich, Leibniz Institute for Age Research, Jena, Germany (Deputy Chairman, Executive Committee);
• Professor Dr. Reinhard Jahn, Max Planck Institute for Biophysical Chemistry, Goettingen, Germany;
• Professor Dr. Ruth Lehmann, New York University School of Medicine, New York, NY, USA;
• Professor Dr. rer. nat. U. Benjamin Kaupp, Centre of Advanced European Studies and Research (caesar), Bonn, Germany;
• Dr. rer. nat. Jan-Michael Peters, Research Institute of Molecular Pathology, Vienna, Austria; 
• Professor Dr. med. Tilman Sauerbruch, Medizinische Klinik und Poliklinik I (Internal Medicine I), University Bonn, Bonn, Germany;
• Professor Hidde Ploegh, PhD, Department of Pathology, Whitehead Institute for Biomedical Research, Cambridge, MA, USA;
• Dr. rer. nat. Ingrid Ohlert, Deutsche Forschungsgemeinschaft, Bonn, Germany (permanent guest).

The Executive Committee

Following consultation with the Board of Trustees, the donors appoint three members of the Board to the Executive Committee. The Executive Committee attends to the regular business of the Foundation and implements the resolutions of the Board. A minimum of two Executive Committee members are required to represent the Boehringer Ingelheim Fonds in legal and non-legal matters.

Members of the Executive Committee

• Dr. Dr. Andreas Barner (Chairman);
• Professor Dr. med. Peter Herrlich (Deputy Chairman);
• Professor Dr. rer. nat. Jan-Michael Peters